Two months on Wegovy: what's actually happening in your body

You're two months in and wondering if this is working, here's what the timeline actually looks like

Picture this: it's week eight, your second Wegovy pen is nearly done, and weight loss has been slower than you hoped. You've heard people talk about dramatic results and you're not sure if you're on track. That uncertainty is one of the most common things people experience at this point, and it's almost always unfounded.

Wegovy's titration schedule exists for a reason. The first four weeks are spent at 0.25 mg, a dose chosen specifically to let your digestive system adapt, not to produce weight loss. By month two you'll typically be on 0.5 mg or beginning 1 mg, still well below the 2.4 mg maintenance dose where the bulk of clinical-trial weight loss was recorded. The STEP 1 trial, published in the New England Journal of Medicine, ran for 68 weeks, two months is roughly weeks five to nine of a journey that takes more than a year to complete.

What is measurable by now is a change in appetite. Most people notice that portions feel smaller naturally, that the impulse to snack has quietened, and that fullness arrives faster. Those are signs the medicine is doing its job at this dose level. Actual scale movement follows appetite change, and it rarely moves in a straight line. If you're tracking weekly weights, one practical check worth doing is averaging your last three readings rather than comparing single days, daily fluctuation from water, salt and digestion can easily mask a genuine downward trend.

Curious about what the next stage looks like? Our page on three months of Wegovy treatment covers what typically shifts once you're into the first maintenance phase.

Side effects at the two-month mark, what's normal and what to act on

Gastrointestinal symptoms are the most discussed part of early Wegovy treatment, and they follow a fairly predictable arc. Nausea, loose stools, constipation and burping are most pronounced in the first three to five weeks and around each dose increase. By the end of month two, many people find the baseline has settled and symptoms are much more manageable, only to notice a brief return if they've just moved to a higher dose.

That pattern is worth understanding. GLP-1 receptor agonists slow the rate at which the stomach empties, which is part of why you feel fuller for longer. The same mechanism causes nausea early on. As your body adjusts, the signal becomes familiar and the intensity fades. Eating slowly, keeping meals smaller and avoiding very fatty or rich foods during the adjustment window all help, the NHS medicines information for semaglutide sets out practical guidance in detail.

A few symptoms warrant prompt attention rather than watchful waiting. Severe, persistent stomach pain (especially if it radiates to your back) should be assessed urgently; pancreatitis is a known but uncommon risk with this class of medicine, and the MHRA issued a Drug Safety Update on exactly this point in January 2026. Gallbladder symptoms, significant dehydration from vomiting or diarrhoea, and any signs of an allergic reaction are also reasons to contact a clinician or call 111 without delay. Unexpected or worsening symptoms should always be discussed with your prescriber rather than waited out.

Our prescribers at nume provide 7-day aftercare for exactly this reason, questions that come up between doses have somewhere to go.

Results at two months: what the data say and how to read your own progress

Two months of Wegovy weight loss data is a snapshot, not a verdict. In the STEP 1 trial, participants on semaglutide 2.4 mg achieved an average weight reduction of around 15% over 68 weeks, but that loss accumulated progressively, with the steepest gains often coming between months three and twelve once maintenance doses were reached. At the eight-week mark, most participants were still in the early titration phase.

That said, two months in you should be able to detect a direction. If your appetite is genuinely suppressed and you're eating less without consciously restricting, you're likely seeing early benefit even if the numbers feel modest. If you've noticed no change at all in hunger or fullness, that's worth raising at your next clinical review, dose, timing, injection technique and other factors can all be assessed.

For context on how treatment typically progresses, the overview on semaglutide covers the full mechanism and evidence base. And if you're already thinking ahead to what month four looks like, the four months on Wegovy page picks up where this one leaves off.

One thing that sometimes surprises people: food choices matter more than people expect when appetite is suppressed. You're eating less, but the quality of what you eat (protein, fibre, hydration) shapes how the medicine performs and how you feel. Some patients find their tastes shift noticeably around this point, sometimes including previously favourite foods feeling less appealing. That's a recognised pattern, not a cause for concern.

Thinking about whether Wegovy is right for where you are now? You can explore your options on our weight loss treatment overview, which sets out the medicines we work with and the clinical framework around them.

What comes next, and when to talk to someone

Month two is a natural checkpoint. You have enough experience of the medicine to have real questions: whether this dose is doing enough, whether the side effects are within normal range, whether your rate of progress is clinically appropriate. Those are exactly the questions a prescriber should answer, not a forum.

The titration road from here runs through 1 mg and 1.7 mg before reaching 2.4 mg, and with the MHRA's April 2026 approval of a dedicated 7.2 mg single-dose pen, there is now a higher maintenance option for adults with BMI of 30 or above, subject to clinical assessment. Dose decisions always sit with your prescriber. What you can do now is make sure you're going into month three with a clear picture of where you are, honest records of any symptoms, and an open conversation with the clinician managing your treatment.

If you're not yet on Wegovy and are considering starting, how to access Wegovy safely in the UK explains the prescription process and what to look for in a regulated online pharmacy. For those already further into treatment, our page on five months on Wegovy addresses what the later months typically look like as you approach or settle into your maintenance dose.

If you have questions about your treatment, or you'd like a clinical review of where you are, check your eligibility with our prescribers, same-day review, 7-day support, no waiting list.